Tenaya Therapeutics Management
Management criteria checks 4/4
Tenaya Therapeutics' CEO is Faraz Ali, appointed in Jun 2018, has a tenure of 5.92 years. total yearly compensation is $2.89M, comprised of 20.5% salary and 79.5% bonuses, including company stock and options. directly owns 0.025% of the company’s shares, worth $87.18K. The average tenure of the management team and the board of directors is 5.4 years and 7.6 years respectively.
Key information
Faraz Ali
Chief executive officer
US$2.9m
Total compensation
| CEO salary percentage | 20.5% |
| CEO tenure | 5.9yrs |
| CEO ownership | 0.02% |
| Management average tenure | 5.4yrs |
| Board average tenure | 7.6yrs |
Recent management updates
Recent updates
Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation
Dec 20
Is Tenaya Therapeutics (NASDAQ:TNYA) In A Good Position To Deliver On Growth Plans?
Aug 08Tenaya Therapeutics (NASDAQ:TNYA) Will Have To Spend Its Cash Wisely
Mar 07Can Tenaya Therapeutics (NASDAQ:TNYA) Afford To Invest In Growth?
Dec 06Tenaya Therapeutics gets U.S. FDA clearance for starting human trial of heart failure treatment
Sep 06Tenaya Therapeutics GAAP EPS of -$0.69 beats by $0.07
Aug 10Is Tenaya Therapeutics (NASDAQ:TNYA) In A Good Position To Deliver On Growth Plans?
Aug 08We're Hopeful That Tenaya Therapeutics (NASDAQ:TNYA) Will Use Its Cash Wisely
Mar 03Companies Like Tenaya Therapeutics (NASDAQ:TNYA) Are In A Position To Invest In Growth
Nov 01Tenaya Therapeutics: Treating Heart Disease Through 3 Product Platforms
Aug 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$594k | -US$124m |
| Sep 30 2023 | n/a | n/a | -US$128m |
| Jun 30 2023 | n/a | n/a | -US$129m |
| Mar 31 2023 | n/a | n/a | -US$124m |
| Dec 31 2022 | US$6m | US$571k | -US$124m |
| Sep 30 2022 | n/a | n/a | -US$116m |
| Jun 30 2022 | n/a | n/a | -US$104m |
| Mar 31 2022 | n/a | n/a | -US$91m |
| Dec 31 2021 | US$5m | US$494k | -US$73m |
| Sep 30 2021 | n/a | n/a | -US$57m |
| Jun 30 2021 | n/a | n/a | -US$49m |
| Mar 31 2021 | n/a | n/a | -US$42m |
| Dec 31 2020 | US$750k | US$425k | -US$38m |
Compensation vs Market: Faraz's total compensation ($USD2.89M) is about average for companies of similar size in the US market ($USD2.42M).
Compensation vs Earnings: Faraz's compensation has been consistent with company performance over the past year.
CEO
Faraz Ali (50 yo)
5.9yrs
Tenure
US$2,890,062
Compensation
Mr. Faraz Ali, M.B.A., serves as Chief Executive Officer since June 2018 & Director since September 2018 at Tenaya Therapeutics, Inc. and served as its Secretary since June 2018. Mr. Ali served as Chief Bu...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.9yrs | US$2.89m | 0.025% $ 87.2k | |
| Scientific Founder | no data | US$280.39k | 0.72% $ 2.5m | |
| Chief Financial & Business Officer | 2.9yrs | US$1.27m | 0.026% $ 93.6k | |
| Chief Medical Officer | 5.4yrs | US$1.38m | 0.032% $ 111.8k | |
| Scientific Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Scientific Founder | no data | no data | no data | |
| Scientific Founder | no data | no data | no data | |
| Scientific Founder | no data | no data | no data | |
| Scientific Founder | no data | no data | no data | |
| Chief Technology Officer | 2.2yrs | no data | no data | |
| Chief Scientific Officer | 6.8yrs | US$2.56m | 0.25% $ 881.0k | |
| Vice President of Investor Relationship & Corporate Communications | no data | no data | no data |
5.4yrs
Average Tenure
56.5yo
Average Age
Experienced Management: TNYA's management team is seasoned and experienced (5.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.9yrs | US$2.89m | 0.025% $ 87.2k | |
| Scientific Founder | 7.6yrs | US$280.39k | 0.72% $ 2.5m | |
| Scientific Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Chairman of the Board | 7.8yrs | US$228.89k | no data | |
| Independent Director | 7.6yrs | US$198.89k | 0.032% $ 112.7k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.2yrs | US$214.89k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 7.6yrs | US$207.39k | 0.038% $ 135.3k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.9yrs | US$202.39k | 0.010% $ 36.7k |
7.6yrs
Average Tenure
60yo
Average Age
Experienced Board: TNYA's board of directors are considered experienced (7.6 years average tenure).